Product Information
DIPYRIDAMOLE 50 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3573 per EA under NDC 68382018801. Its NADAC has been published 321 times since Nov 28, 2013.
FDA first approved this application on Jan 28, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382018801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIPYRIDAMOLEApproval Type
Generic (ANDA)
FDA Application
ANDA040874FDA Approved
1/28/2008
TE Code
AB
On Market Since
5/22/2008
Pharmacological Classes
Price Statistics
The NADAC for DIPYRIDAMOLE 50 MG TABLET has been published 321 times since Nov 28, 2013, and over the history we have for it it has risen 98.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3573 per EA |
|---|---|
| All-time high | $1.3373 (Jun 14, 2023) |
| All-time low | $0.1369 (Jan 20, 2016) |
| 52-week high | $0.3623 |
| 52-week low | $0.2736 |
| Median price | $0.2768 |
| Average price | $0.4148 |
| Largest weekly change | +677.8% (Aug 24, 2022) |
| Weeks tracked | 321 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dipyridamole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Platelet Aggregation Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIPYRIDAMOLE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPYRIDAMOLE 50 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3573 per EA (NDC 68382018801), effective Sep 30, 2026.
How has the price of DIPYRIDAMOLE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPYRIDAMOLE 50 MG TABLET has risen 98.7%. It has been tracked across 321 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIPYRIDAMOLE 50 MG TABLET?
Since Nov 28, 2013, the NADAC for DIPYRIDAMOLE 50 MG TABLET has ranged from a low of $0.1369 (Jan 20, 2016) to a high of $1.3373 (Jun 14, 2023), with a median of $0.2768 per EA.
Are there cheaper alternatives to DIPYRIDAMOLE 50 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIPYRIDAMOLE 50 MG TABLET, is $0.2691 per EA — about 25% below DIPYRIDAMOLE 50 MG TABLET.
Who manufactures DIPYRIDAMOLE 50 MG TABLET?
DIPYRIDAMOLE 50 MG TABLET (NDC 68382018801) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.